Boom! Lawyered

The podcast discusses the recent Florida Supreme Court decisions removing abortion rights from the state constitution, the implications of a 15-week ban, upcoming voter initiatives to protect abortion access, and the influence of DeSantis-appointed judges on reproductive rights.

Legal professional Erin Hawley discusses Mifepristone's day at the Supreme Court, highlighting surprising insights and reactions. Hosts delve into the intense courtroom arguments and explore the complexities of ultrasounds in medication abortion. They also analyze federal conscience protections and patient care perspectives, shedding light on the evolving landscape of abortion rights and access.

Exploring the high-stakes abortion pill case at the Supreme Court, highlighting the potential impact on medication abortion access and the resurrection of the Comstock Act. Scrutinizing biased scientific studies on abortion reversal, discussing legal standings in the lawsuit, and addressing frustration with the legal system.

The podcast discusses the Fifth Circuit Court's ruling on teens' access to birth control without parental consent, potentially jeopardizing Title X. It highlights the clash between federal law and Texas's parental consent law, sparking concerns among advocates about restricting teens' reproductive health choices.

The next major Supreme Court fight over nationwide abortion access since the overturn of Roe v. Wade is coming up. Oral arguments in FDA v. Alliance for Hippocratic Medicine, regarding mifepristone access, one of two drugs used in medication abortion, is set for March 26, and the justices could potentially set access back decades.In this flashback episode, Jess and Imani discuss how anti-choice activists are using scare tactics—and language like “chemical abortion”—to stigmatize mifepristone. Decades of research and data show mifepristone is safe and effective.Rewire News Groupis a nonprofit media organization, which means Boom! Lawyered is only made possible with the support of listeners like you! If you can, please join our team by donating here.And sign up forThe Fallout, a weekly newsletter written by Jess that’s exclusively dedicated to covering every aspect of this unprecedented moment.

Catch up with stories you may have missed at rewirenewsgroup.com.Rewire News Groupis a nonprofit media organization, which means Boom! Lawyered is only made possible with the support of listeners like you! If you can, please join our team by donating here.And sign up forThe Fallout, a weekly newsletter written by Jess that’s exclusively dedicated to covering every aspect of this unprecedented moment.

Junk science is everywhere surrounding the big medication abortion case the Supreme Court will hear in late March, FDA v. Alliance for Hippocratic Medicine. The junk science is so improper, in fact, that the academic publishers who published studies that were cited by the plaintiffs—and the lower court judge who ruled on it, Matthew Kacsmaryk—retracted them.As Imani says in this week's episode, the Supreme Court may very well rely on a bunch of bozos when it decides to maintain the restrictions on access to abortion that were imposed by Kacsmaryk and the Fifth Circuit. So if the evidence upon which that decision was based is garbage, the Court should rule in favor of the FDA. Right?Rewire News Group is a nonprofit media organization, which means Boom! Lawyered is only made possible with the support of listeners like you! If you can, please join our team by donating here.And sign up for The Fallout, a weekly newsletter written by Jess that’s exclusively dedicated to covering every aspect of this unprecedented moment.

The Pennsylvania Supreme Court issued a ruling this week regarding abortion, and there's been some confusion around it. No, the court didn't find a fundamental right to abortion in the state constitution. However, the justices did pave the way for that possibility as they weighed whether Medicaid must cover abortions in Pennsylvania.Rewire News Group is a nonprofit media organization, which means Boom! Lawyered is only made possible with the support of listeners like you! If you can, please join our team by donating here.And sign up for The Fallout, a weekly newsletter written by Jess that’s exclusively dedicated to covering every aspect of this unprecedented moment.

After the Supreme Court overturned Roe v. Wade, the Biden administration issued guidance on the Emergency Medical Treatment and Active Labor Act (EMTALA) to say that emergency care at Medicare-funded hospitals includes abortion care.So why, when there has been a clear violation of that, did the administration side with the hospital over the patient who needed care and throw doctors under the bus?This week, Jess and Imani get into Jaci Statton's case—the perfect example of what's wrong with relying on EMTALA to enforce abortion rights.Rewire News Group is a nonprofit media organization, which means Boom! Lawyered is only made possible with the support of listeners like you! If you can, please join our team by donating here.And sign up for The Fallout, a weekly newsletter written by Jess that’s exclusively dedicated to covering every aspect of this unprecedented moment.

Last week, the 11th Circuit Court of Appeals allowed Alabama’s gender-affirming care ban to go into effect, and that’s terrible not just for Alabama, but also for Georgia and Florida, both of which are located in the 11th Circuit and have gender-affirming care bans being litigated right now. Hear from Jess and Imani, who've got everything you need to know about Eknes-Tucker v. Ivey and why the ruling is flat out wrong.Mentioned in this episode:This Is the Big Trans Rights Case That SCOTUS Could Hear Next YearThis Case Could End Teens' Birth Control AccessRewire News Group is a nonprofit media organization, which means Boom! Lawyered is only made possible with the support of listeners like you! If you can, please join our team by donating here.And sign up for The Fallout, a weekly newsletter written by Jess that’s exclusively dedicated to covering every aspect of this unprecedented moment.